Papers
6
Total Citations
200
H-Index
5
About
B. Lallemant is a leading figure in head and neck surgical oncology, with a primary focus on advancing transoral robotic surgery (TORS) for the treatment of laryngopharyngeal cancers. His major contributions center on demonstrating the safety, efficacy, and functional benefits of TORS as a minimally invasive, organ-preserving alternative to traditional chemoradiotherapy. Through his work with the French GETTEC cooperative group, Lallemant has provided pivotal clinical evidence, including a landmark study on supraglottic squamous cell carcinoma (79 citations) and a multicentric morbidity and mortality review (70 citations), which together have helped establish TORS as a standard approach. He has also pioneered the application of TORS for challenging anatomical sites, such as the posterior pharyngeal wall, and has been instrumental in identifying rare complications like spondylodiscitis, thereby improving patient safety protocols. With over 200 cumulative citations, Lallemant’s research has significantly shaped modern head and neck surgery, offering patients reduced toxicity and faster recovery. His early work, including a forward-looking 2011 review on the future of TORS, underscores his role as a visionary in the field, making him a key reference for surgeons and researchers exploring robotic-assisted interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6